carbamazepine has been researched along with vecuronium bromide in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Norman, J | 1 |
Ebrahim, Z; Whalley, DG | 1 |
Alloul, K; Ebrahim, Z; Shutway, F; Varin, F; Whalley, DG | 1 |
Born, JD; Brichant, JF; Hans, P; Lamy, M; Pieron, F; Pieyns, P | 1 |
Johnson, JO; Tobias, JD | 1 |
Greenblatt, DJ; Martyn, JA; Soriano, SG; Sullivan, LJ; Venkatakrishnan, K | 1 |
1 trial(s) available for carbamazepine and vecuronium bromide
Article | Year |
---|---|
Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients.
Topics: Adult; Anesthesia Recovery Period; Anticonvulsants; Carbamazepine; Drug Resistance; Epilepsy; Female; Humans; Male; Middle Aged; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide | 1996 |
7 other study(ies) available for carbamazepine and vecuronium bromide
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Resistance to vecuronium.
Topics: Adult; Carbamazepine; Drug Resistance; Electroencephalography; Epilepsy; Female; Humans; Neostigmine; Vecuronium Bromide | 1993 |
Influence of carbamazepine on the dose-response relationship of vecuronium.
Topics: Adolescent; Adult; Carbamazepine; Dose-Response Relationship, Drug; Drug Resistance; Electromyography; Female; Humans; Male; Middle Aged; Muscle Contraction; Neuromuscular Junction; Vecuronium Bromide | 1994 |
Elevated plasma alpha 1-acid glycoprotein levels: lack of connection to resistance to vecuronium blockade induced by anticonvulsant therapy.
Topics: Adult; Alprazolam; Anticonvulsants; Atropine; Biomarkers; Carbamazepine; Drug Interactions; Drug Resistance; Humans; Hydroxyzine; Hypnotics and Sedatives; Middle Aged; Neuromuscular Nondepolarizing Agents; Neurosurgery; Orosomucoid; Phenobarbital; Phenytoin; Vecuronium Bromide | 1997 |
Rapacuronium administration to patients receiving phenytoin or carbamazepine.
Topics: Adult; Anticonvulsants; Brain Injuries; Brain Neoplasms; Carbamazepine; Craniotomy; Drug Interactions; Humans; Intracranial Hypertension; Male; Monitoring, Intraoperative; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Phenytoin; Synaptic Transmission; Time Factors; Vecuronium Bromide | 2001 |
Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy.
Topics: Adolescent; Anesthesia, General; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Interactions; Drug Resistance; Electromyography; Female; Half-Life; Humans; Male; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Orosomucoid; Phenytoin; Vecuronium Bromide | 2001 |